COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS CASPOFUNGIN IN THE TREATMENT OF INVASIVE CANDIDA INFECTION IN CHINA

被引：0
|
作者：
Wang, C. [1 ]
Dong, H. [1 ]
Sun, L. [1 ]
机构：
[1] Shenyang Pharmaceut Univ, Shenyang, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1604
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN61
引用
收藏
页码：A275 / A276
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN FOR THE TREATMENT OF INVASIVE MUCORMYCOSIS IN JORDAN
    Naser, A.
    Bilbisi, M.
    Mousa, R.
    VALUE IN HEALTH, 2023, 26 (12) : S145 - S145
  • [22] Cost-effectiveness analysis of voriconazole versus amphotericin B in the treatment of invasive aspergillosis in Spain
    Grau, S
    Mateu-de, AJ
    Soto, J
    Muñoz, M
    Salas, E
    VALUE IN HEALTH, 2003, 6 (06) : 750 - 751
  • [23] Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis
    Zhou, Hua
    Yan, Mengxia
    Che, Datian
    Wu, Bin
    JHEP REPORTS, 2024, 6 (04)
  • [24] Cost-minimization analysis of voriconazole and caspofungin for the treatment of invasive candida and aspergillosis infections in Spain
    Domínguez-Gil, HA
    Herranz, MI
    Garcia, VM
    Rejas, J
    VALUE IN HEALTH, 2004, 7 (06) : 764 - 764
  • [25] COST-EFFECTIVENESS ANALYSIS OF SULODEXIDE VERSUS DIOSMIN IN THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY IN CHINA
    Yang, F.
    Fu, Y.
    Xiao, D.
    Xuan, J.
    VALUE IN HEALTH, 2020, 23 : S130 - S130
  • [26] Cost-Effectiveness Analysis of Micafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation in Korea
    Sohn, Hyun Soon
    Lee, Tae-Jin
    Kim, Jinhyun
    Kim, Donghwan
    CLINICAL THERAPEUTICS, 2009, 31 (05) : 1105 - 1115
  • [27] Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
    Li, Min
    Cao, Yuxin
    Huang, Hao
    Qin, Gang
    Chu, Minjie
    Zou, Meiyin
    Zhuang, Xun
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [28] Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
    Min Li
    Yuxin Cao
    Hao Huang
    Gang Qin
    Minjie Chu
    Meiyin Zou
    Xun Zhuang
    BMC Public Health, 23
  • [29] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Floros, Lefteris
    Kuessner, Daniel
    Posthumus, Jan
    Bagshaw, Emma
    Sjolin, Jan
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [30] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Lefteris Floros
    Daniel Kuessner
    Jan Posthumus
    Emma Bagshaw
    Jan Sjölin
    BMC Infectious Diseases, 19
12345